Form 4: Natures Sunshine Executive Sells 3,800 Shares
Insider Transaction Report
Natures Sunshine Products EVP and General Counsel Nathan G. Brower reported the sale of 3,800 common shares at $20.81 per share.
Summary
- Nathan G. Brower, Executive Vice President and General Counsel of Natures Sunshine Products Inc. (NATR), reported a transaction.
- The transaction involved the sale of 3,800 common shares.
- The shares were sold at a price of $20.81 per share.
- The total value of the shares sold was $79,078.
- Following this transaction, Mr. Brower beneficially owns 46,735 common shares directly.
- The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to an insider sale, but mitigated by the fact it was executed under a Rule 10b5-1 plan, suggesting a pre-scheduled personal financial event rather than a reaction to new negative information.
Negatives
- An insider sale, even if pre-planned, can sometimes be perceived by the market as a lack of confidence, though the Rule 10b5-1 plan mitigates this concern.
Future Outlook
NA
Industry Context
This filing reports an individual insider transaction and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders may view the sale by an executive as a minor negative signal, potentially leading to short-term price fluctuations. However, the disclosure of a 10b5-1 plan typically reduces concerns about the executive's confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 11/14/2025 | Date of transaction (sale of common shares) |
| 11/18/2025 | Date the Form 4 was signed and filed |
Recommendation
holdThe reported transaction is an insider sale by an executive, but it was conducted under a Rule 10b5-1 plan. Such plans are typically established for personal financial management and do not necessarily reflect a change in the executive's outlook on the company's performance. While insider sales can sometimes be a negative signal, this specific transaction, given its pre-planned nature and relatively small size compared to total outstanding shares, is unlikely to warrant a change in investment thesis. Investors should monitor future filings and broader company performance rather than reacting solely to this routine insider transaction.
Keywords
Natures Sunshine Products, NATR, Insider Trading, Form 4, Stock Sale, Nathan Brower, Executive Transaction, Common Shares, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.